Prevalence of Polycystic Ovary Syndrome and Related Disorders in Mexican Women
Overview
Affiliations
Background/aims: Polycystic ovary syndrome (PCOS) has been found to affect 4-8% of women of reproductive age; however, in Mexican-Americans a prevalence of 12.8% has been reported. This study determines the prevalence of PCOS in a sample of Mexican women.
Methods: This prospective cross-sectional study included 150 female Mexican volunteers aged 20-45 years. Menstrual cycles were recorded and hirsutism was graded. Pelvic ultrasound was performed and androgen levels were measured. PCOS was diagnosed by hyperandrogenism and/or hyperandrogenemia, and oligo-ovulation (NIH 1990 criteria), and also by 2 of 3 findings: oligo-ovulation, clinical and/or biochemical hyperandrogenism and polycystic ovaries (PCO) (Rotterdam 2003 criteria), excluding other disorders.
Results: Nine of the 150 women were diagnosed with PCOS, a prevalence of 6.0% (95% CI: 1.9-10.1%), according to NIH criteria. The ultrasound morphology added one patient to give ten PCOS patients, a prevalence of 6.6% (95% CI: 2.3-10.9%) according to Rotterdam criteria. All PCOS patients presented oligo-ovulation, 9 had hirsutism and 7 of them had acne. Eight of the 10 PCOS patients had morphologic characteristics of PCO.
Conclusion: The prevalence of PCOS in Mexican women is approximately 6.0%, similar to other populations, but lower than 12.8% reported in Mexican-American women.
Salari N, Nankali A, Ghanbari A, Jafarpour S, Ghasemi H, Dokaneheifard S Arch Gynecol Obstet. 2024; 310(3):1303-1314.
PMID: 38922413 DOI: 10.1007/s00404-024-07607-x.
Polymorphism, along with Deletion of and Genes, Strongly Influences Female Infertility Risk.
Casteleiro Alves M, Almeida M, Oliani A, Breitenfeld L, Ramalhinho A Antioxidants (Basel). 2023; 12(4).
PMID: 37107315 PMC: 10135531. DOI: 10.3390/antiox12040940.
Prevalence of Polycystic Ovarian Syndrome in India: A Systematic Review and Meta-Analysis.
Bharali M, Rajendran R, Goswami J, Singal K, Rajendran V Cureus. 2023; 14(12):e32351.
PMID: 36628015 PMC: 9826643. DOI: 10.7759/cureus.32351.
Yasmin A, Roychoudhury S, Paul Choudhury A, Ahmed A, Dutta S, Mottola F Life (Basel). 2022; 12(12).
PMID: 36556340 PMC: 9785838. DOI: 10.3390/life12121974.
[Proinflammatory cytokines in polycystic ovarian syndrome].
Garcia-Saenz M, Ferreira-Hermosillo A, Lobaton-Ginsberg M Rev Med Inst Mex Seguro Soc. 2022; 60(5):569-576.
PMID: 36049035 PMC: 10396056.